By Associate Professor Yeh Chen Lee

Conference Papers

Nishio S; Pardo B; Hudson E; Rulli E; Antill Y; Lee C; Rabaglio M; Heitz F; Leitner K; Lai C-H; Uggeri S; Manso L; Harano K; Allan K; Lee YC; Tognon G; Canova S; Petrella MC; Gadducci A; Colombo N, 2024, '523 Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of AtTEnd/ENGOT-EN7 trial', in Oral Sessions, BMJ Publishing Group Ltd, presented at ESGO 2024 Congress Abstracts, http://dx.doi.org/10.1136/ijgc-2024-esgo.26

Colombo N; Harano K; Hudson E; Galli F; Antill Y; Choi CH; Rabaglio M; Marmé F; Petru E; Lai C-H; Biagioli E; Fariñas-Madrid L; Takehara K; Allan K; Lee YC; Piovano E; Zamagni C; Tasca G; Ferrero A; Barretina-Ginesta M-P, 2024, '546 AtTEnd/ENGOT-EN7: phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma', in Oral Sessions, BMJ Publishing Group Ltd, pp. A21.1 - A21, presented at ESGO 2024 Congress Abstracts, http://dx.doi.org/10.1136/ijgc-2024-esgo.27

Buchanan D; Joo J-HE; Mahmood K; Georgeson P; Walker R; Robledo K; Cummins M; Spurdle AB; Smith D; Clendenning M; Como J; Preston S; Yip S; Andrews J; Kok P-S; Lee YC; Stockler M; Mileshkin L; Antill Y, 2024, '713 The impact of cause of mismatch repair deficiency and other molecular markers on clinical outcomes with the use of durvalumab in advanced endometrial cancer in the phase 2 PHAEDRA trial (ANZGOG1601)', in Poster and E-Posters, BMJ Publishing Group Ltd, pp. A504.1 - A504, presented at ESGO 2024 Congress Abstracts, http://dx.doi.org/10.1136/ijgc-2024-esgo.988

Oaknin A; Lorusso D; Pietzner K; Lee J-Y; Cibula D; Lee YC; Schilder R; Auranen A; Gao B; Tan D; Oza A; Miller R; Salutari V; Tasca G; O’Malley D; Monk B; Pothuri B; Lu L; Berman C; Borgman A; Wendel Naumann R, 2024, 'TP010/#1537  Efficacy and safety of luveltamab tazevibulin in patients with recurrent platinum-resistant ovarian cancer: the reframe-01 (GOG-3086, ENGOT-79ov, and APGOT-OV9) phase 2/3 study', in E-Poster Viewing Abstracts – Trials in Progress, BMJ Publishing Group Ltd, pp. A351.1 - A351, presented at IGCS 2024 Annual Meeting Abstracts, http://dx.doi.org/10.1136/ijgc-2024-igcs.612

Werner B; Powell E; Duggan J; Lee YC; Athavale R; Dean M; Warton K; Ford C, 2023, 'Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in a cohort of patients with advanced ovarian cancer', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, BMJ PUBLISHING GROUP, pp. A32 - A33, http://dx.doi.org/10.1136/ijgc-2023-IGCS.47

Au-Yeung G; Bressel M; Prall O; Opar P; Andrews J; Mongta S; Lee YC; Gao B; Meniawy T; Baron-Hay S; Black A; Kichenadasse G; Ananda S; Fox P; Bowtell D; Mileshkin L, 2023, 'PO003/#269  Ignite: a phase II signal-seeking trial of adavosertib targeting recurrent high grade serous ovarian cancer with cyclin E1 over-expression with and without gene amplification', in Plenary 01: Oral Abstract Presentations, BMJ Publishing Group Ltd, pp. A2 - A3, presented at IGCS 2023 Annual Meeting Abstracts, http://dx.doi.org/10.1136/ijgc-2023-igcs.3

Mileshkin LR; Moore KN; Barnes EH; Lee YC; Gebski V; Narayan K; Bradshaw N; Diamante K; Fyles AW; Small W; Gaffney DK; Khaw P; Brooks S; Thompson JS; Huh WK; Carlson M; Robison K; Rischin D; Stockler MR; Monk BJ, 2022, 'Staging locally advanced cervical cancer with FIGO 2018 versus FIGO 2008: Impact on overall survival and progression-free survival in the OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 03 June 2022 - 07 June 2022

Sivakumaran T; Krasovitsky M; Lee YC; Norris C; Friedlander M, 2020, '403 Treatment patterns post PARP inhibitor in epithelial ovarian cancer patients: results from an Australian, retrospective, multi-institute cohort study', in Poster, BMJ Publishing Group Ltd, pp. A167.1 - A167, presented at IGCS 2020 Annual Meeting Abstracts, http://dx.doi.org/10.1136/ijgc-2020-igcs.348

Wilson MK; Lheureux S; Cyriac S; Dhani NC; Butler M; Gutierrez D; Mandilaras V; Ethier J-L; Colombo I; Lee YC; Kanjanapan Y; Bonilla L; Hunt W; Bowering V; Oza AM, 2017, 'Clinical trial of biopsies in oncology: Patient-reported impact (BIOPSY).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2017 - 07 June 2017, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.e17034

Colombo I; Lien S; Yang C; Clouthier DL; Bonilla L; Cyriac S; Ethier J-L; Lee YC; Kanjanapan Y; Mandilaras V; Dhani NC; Butler MO; Oza AM; Quintos J; Chow H; Pugh TJ; Ohashi PS; Siu LL; Lheureux S, 2017, 'Immunologic and genomic characterization of high grade serous ovarian cancer (HGSOC) in patients (pts) treated with pembrolizumab (Pembro) in the phase II INSPIRE trial.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, IL, Chicago, 02 June 2017 - 07 June 2017, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.5581

Lee YC; Milne RL; Smith C; Picken S; Camm S; McLachlan S-A; Friedlander M; Hopper JL; Phillips K-A, 2016, 'Risk of uterine cancer in BRCA1 and BRCA2 mutation carriers.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 03 June 2016 - 07 June 2016, http://dx.doi.org/10.1200/JCO.2016.34.15_suppl.1529

Birnie KA; Yip Y; Ng D; Kirschner MB; Reid G; Thompson PJ; Lee YC; Badrian B; Mutsaers SE, 2015, 'LOSS OF MICRORNA-223 AND C-JUN-TERMINAL KINASE (JNK) SIGNALLING CONTRIBUTE TO THE OVER-EXPRESSION OF STATHMIN IN MALIGNANT PLEURAL MESOTHELIOMA', in RESPIROLOGY, WILEY-BLACKWELL, AUSTRALIA, Queensland, pp. 146 - 146, presented at Thoracic Society Australia New Zealand Australian New Zealand Society Respiratory Science Annual Scientific Meeting 2015, AUSTRALIA, Queensland, 27 March 2015 - 01 April 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000351464400379&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Rosenstengel A; Tremblay A; Slade M; Garske L; Ng B; Lamb C; Clive A; Mishra E; Boshuizen R; Fysh E; Lee YCG, 2013, 'PLEURAL INFECTIONS ASSOCIATED WITH INDWELLING PLEURAL CATHETERS (IPC)', in RESPIROLOGY, WILEY-BLACKWELL, pp. 31 - 31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000315589700112&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page